KPTI 주요 통계
고가
7.16
개시가
7.14
거래량
148.62K
저가
6.88
전일 종가
7.18
거래대금
1.04M
52주 최고가
10.99
상대 거래량
0.228
변동폭 (%)
3.83%
52주 최저가
3.65
회전율
0.66%
시가총액
162.71M
PER (TTM)
--
PER (연간)
--
PBR
-0.61
PSR
1.08
주당순이익(EPS)
-15.087
배당금(TTM)
0
배당수익률
0.00%
발행주식수
22.66M
통화 단위
USD
KPTI 가격 수익률
7 일
30 일
90 일
180 일
연초 이후
1 년
KPTI 자금 흐름 분포
KPTI 일일 공매도 거래량
KPTI 공매도 잔고 내역
KPTI 주식 스냅샷
As of 2026-07-23, the Karyopharm Therapeutics Inc. (KPTI) stock price today is 6.98. Based on this price, the company has a market capitalization of $162.71M, with a P/E ratio of --.
On 2026-07-23, KPTI traded between 6.88 and 7.16. Today’s stock price is 1.45% above the daily low and 2.51% below the daily high, placing KPTI 낮은 구간에 its most recent trading range.
Trading volume currently stands at 148.62K, compared with an average daily volume of 652.80K. This suggests that trading activity is 평소 수준을 크게 밑도는 than usual.
Over the past year, Karyopharm Therapeutics Inc. shares have traded between 3.65 and 10.99. At today’s price, KPTI is 91.23% above its 52-week low and 36.49% below its 52-week high.
KPTI 관련 뉴스
소개 KPTI
회사 이름
Karyopharm Therapeutics Inc.
섹터
Health Technology
산업
Pharmaceuticals: Major
거래소
Nasdaq
직원 수
228
랏 크기
100
공식 웹사이트
통화 단위
USD
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Related Stocks
